Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
Indivior ( (INDV) ) just unveiled an update.
Indivior PLC announced the results of its Annual General Meeting (AGM) held on May 8, 2025, where all resolutions were passed by shareholders. Notably, there was a significant number of votes against the election of Dr. David Wheadon, with 18.29% voting against him. The AGM results reflect shareholder engagement and decision-making on key governance issues, impacting the company’s strategic direction and stakeholder relations.
More about Indivior
Indivior is a global pharmaceutical company focused on developing medicines to treat opioid use disorder (OUD). The company aims to transform OUD from a global crisis into a recognized and treated chronic disease, with a portfolio of treatments available in over 30 countries. Headquartered in Richmond, VA, Indivior employs over 1,000 individuals worldwide.
Average Trading Volume: 379,473
Technical Sentiment Signal: Sell
Current Market Cap: £1.08B
Learn more about INDV stock on TipRanks’ Stock Analysis page.
Trending Articles:
Looking for a trading platform? Check out TipRanks' Best Online Brokers guide, and find the ideal broker for your trades.
Report an Issue